Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-138
Closed -$7K 172
2019
Q2
$7K Buy
+138
New +$6.92K 0.01% 136
2018
Q1
Sell
-102
Closed -$5K 310
2017
Q4
$5K Buy
+102
New +$4.71K ﹤0.01% 252
2015
Q2
Sell
-165
Closed -$10K 368
2015
Q1
$10K Buy
+165
New +$9.46K 0.01% 139

Other funds holding GSK

Ruggie Capital Group's GSK Position: Q3 2019 in Review

Ruggie Capital Group sold out of GSK (GSK) in Q3 2019, closing a stake of 138 shares — an estimated $7K sold.

Ruggie Capital Group first reported a position in GSK in Q1 2015 and held it in 3 quarters. The position peaked at $10K in Q1 2015. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Ruggie Capital Group reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 138 GSK shares in Q3 2019, an estimated $7K.
  • Ruggie Capital Group first reported a position in GSK in Q1 2015 and held it in 3 quarters.
  • Ruggie Capital Group's GSK position peaked at $10K in Q1 2015.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Ruggie Capital Group's 13F filing for Q3 2019, filed 6 Nov 2019.